Tag "Signus"

Back to homepage
COMPANY NEWS

ST-Line – Next in fusion

Promotional feature With its new ST-Line, SIGNUS has applied the progress from endoprosthetic research to spinal surgery Regardless of the application, the excellent mechanical and biological properties of titanium and

COMPANY NEWS

Success of first JASPIS ST® surgery in Australia

Neurosurgeon Dr Andrew Miles, Neurospine Institute, Western Australia successfully completed the first JASPIS® ST surgery in Australia. Dr Miles’ first JASPIS ST case was a patient with degenerative disc disease

ARTICLES

Cervical disc arthroplasty

Promotional feature Degenerative cervical disc diseases are generally treated with a discectomy and fusion surgery after failure of a conservative therapy. Even if the patient’s satisfaction and the success of

ARTICLES

Signus product features

JASPIS® ST – Anterior Cervical Fusion Our latest member in the ST-Line by SIGNUS family, JASPIS® ST is implanted in the C3 – TH1 spinal region using the proven Smith-Robinson technique. As

ARTICLES

Trade tools – SIGNUS Medizintechnik GmbH

Promotional feature ATHLET – The real winner! Anterior cervical corpectomy and fusion (ACCF) has become standard procedure for patients with spondylotic myelopathy due to multisegmental stenosis of the cervical canal.

COMPANY NEWS

Clinical study shows patient satisfaction with ROTAIO®

Clinical study shows patient satisfaction with ROTAIO® A US patent has been granted for the artificial cervical disc prosthesis ROTAIO by SIGNUS. The patent relates to the anatomical prosthesis design

PRODUCT NEWS

DIPLOMAT – Greater flexibility and efficiency for all treatments

DIPLOMAT – Greater flexibility and efficiency for all treatments The new DIPLOMAT thoracolumbar fixation system was developed to achieve the optimal balance between clinical performance and user-friendliness. The DIPLOMAT pedicle

NEWS News Centre PRODUCT NEWS

FDA Clearance for Signus Mobisc® II ST interbody fusion device

SIGNUS Medizintechnik, the German developer and manufacturer of spinal implants, has received FDA clearance to commercially release its Signus MOBIS ® II ST system, which is comprised of a line of structural titanium